STE insider plans cashless exercise sale of 3,495 shares on NYSE

Rhea-AI Filing Summary

STERIS plc filed a Form 144 reporting a proposed sale of 3,495 ordinary shares with an aggregate market value of $844,249, to be sold on the NYSE through Charles Schwab on 08/11/2025. The shares were acquired on 08/11/2025 via an employee stock option exercise and payment was completed through a broker cashless exercise. The filing reports 98,490,606 shares outstanding and states Nothing to Report for securities sold in the past three months. The filing does not identify the person for whose account the securities are to be sold.

Insights

Financial Analyst

TL;DR: Small, routine insider sale following an option exercise; unlikely to move the market given the size relative to outstanding shares.

The Form 144 shows a proposed disposition of 3,495 ordinary shares valued at $844,249, to be executed through Charles Schwab on the NYSE. Using the reported 98,490,606 shares outstanding, the sale equals approximately 0.0036% of total shares, indicating a very small issuer-level impact. The shares were acquired the same day via an employee stock option exercise and paid via a broker cashless exercise. There are no reported sales by this person in the past three months. Overall, this disclosure appears routine and not materially market-moving.

Corporate Governance Expert

TL;DR: Transaction arises from a cashless exercise of employee stock options and is disclosed under Rule 144; procedural but lacks seller identification.

The filing documents an employee stock option exercise on 08/11/2025 with a subsequent proposed sale of the resulting 3,495 shares through Charles Schwab. Payment was handled as a broker payment for a cashless exercise, a standard mechanism for option holders to cover exercise costs. The Form 144 confirms no sales in the prior three months but does not name the person for whose account the sale will occur, which is a notable omission in the party identification field of the filing. From a governance perspective, the disclosure meets Rule 144 reporting mechanics but provides limited context about the seller.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	3495	844249.00	98490606	08/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	08/11/2025	Employee Stock Option Exercise	STERIS plc			3495	08/11/2025	Broker Payment for Cashless Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the STERIS (STE) Form 144 disclose?

The filing discloses a proposed sale of 3,495 ordinary shares valued at $844,249 to be sold on the NYSE via Charles Schwab on 08/11/2025.

How were the 3,495 STERIS shares acquired?

The shares were acquired on 08/11/2025 through an employee stock option exercise, with payment completed as a broker payment for a cashless exercise.

How many STERIS shares are outstanding and what percentage does this sale represent?

The filing reports 98,490,606 shares outstanding. The proposed sale of 3,495 shares represents approximately 0.0036% of outstanding shares.

Has the seller sold any STERIS securities in the past three months?

The filing states: Nothing to Report for securities sold during the past three months.

Which broker is handling the sale listed on the Form 144?

The broker listed is Charles Schwab & Co., Inc. at the address provided: 3000 Schwab Way, Westlake, TX 76262.

Does the Form 144 identify the person for whose account the securities are to be sold?

No. The filing does not provide the name of the person for whose account the securities are to be sold in the issuer/person fields shown.